Coronavirus
223
8
9
131
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
40 trials with published results (18%)
Research Maturity
131 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.4%
21 terminated out of 223 trials
86.2%
-0.3% vs benchmark
14%
31 trials in Phase 3/4
31%
40 of 131 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 131 completed trials
Clinical Trials (223)
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
An Observational Study of Patients With Coronavirus Disease 2019
Inflammatory Signal Inhibitors for COVID-19 (MATIS)
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
A Study of a Candidate COVID-19 Vaccine (COV001)
Investigating a Vaccine Against COVID-19
COVID-19 Biorepository
Antibody Detection of Vaccine-Induced Secretory Effects
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
A Study to Explore the Role of Gut Flora in COVID-19 Infection
SARS-CoV-2 Human Challenge Characterisation Study
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2